Drug Profile
Hypoxoside
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Essential Sterolin Products
- Developer Essential Sterolin Products; Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lung cancer
Most Recent Events
- 02 Sep 1998 Profile reviewed
- 16 Jan 1996 Phase-I clinical trials for Lung cancer in South Africa (PO)